XCE Tirzepatide is a high-purity peptide compound developed for research applications. This dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist shows promising potential in metabolic research.
The molecular structure of XCE Tirzepatide (C225H348N48O68) features modifications that enhance its stability and solubility compared to similar compounds. Research indicates this dual agonist behavior produces significant effects in glucose regulation studies.
In clinical research settings, XCE Tirzepatide has demonstrated notable effects on metabolic parameters. The compound's unique mechanism of action combines the benefits of both GIP and GLP-1 receptor activation in a single molecule.
Our XCE Tirzepatide is supplied as a white lyophilized powder with 99.9% purity, packaged in sterile vials under controlled conditions to ensure stability and research reliability.
Storage recommendations include maintaining the product at controlled temperatures between 2-8°C, protected from light and moisture. Proper handling procedures should be followed to preserve the compound's research integrity.
This product is intended for laboratory research purposes only. All specifications and analytical data are available upon request for qualified research institutions.